- Lobbying
- Lobbying by DIGITAL THERAPEUTICS ALLIANCE, INC
Lobbying Relationship
Bills mentioned
H.R.7051: Access to Prescription Digital Therapeutics Act of 2022
Sponsor: Mike Thompson (D-Calif.)
S.3791: Access to Prescription Digital Therapeutics Act of 2022
Sponsor: Shelley Moore Capito (R-W.Va.)
H.R.1458: Access to Prescription Digital Therapeutics Act of 2023
Sponsor: Kevin Hern (R-Okla.)
S.723: Access to Prescription Digital Therapeutics Act of 2023
Sponsor: Jeanne Shaheen (D-N.H.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Andrew Molnar | Chief Executive Officer |
Sara Elalamy | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
U.S. House of Representatives
Medicare
U.S. House of Representatives
Medicare
U.S. House of Representatives
Medicare
U.S. House of Representatives
Medicare
U.S. House of Representatives
Medicare
U.S. House of Representatives
Medicare
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
Health & Human Services - Dept of (HHS)
U.S. House of Representatives
U.S. House of Representatives
Food & Drug Administration (FDA)
Office of Science & Technology Policy (OSTP)
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate